These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study. Teklay G; Teklu T; Legesse B; Tedla K; Klinkenberg E BMC Public Health; 2016 Aug; 16(1):840. PubMed ID: 27543096 [TBL] [Abstract][Full Text] [Related]
30. Monitored isoniazid prophylaxis for low-risk tuberculin reactors. Moulding T Ann Intern Med; 1998 Jun; 128(12 Pt 1):1048. PubMed ID: 9625675 [No Abstract] [Full Text] [Related]
31. Isoniazid prophylaxis in end-stage renal disease. Bal AM Transpl Infect Dis; 2006 Dec; 8(4):242-3; author reply 243. PubMed ID: 17116141 [No Abstract] [Full Text] [Related]
32. Protecting young healthcare trainees from tuberculosis: can we overcome apathy? Pai M; Christopher DJ Natl Med J India; 2011; 24(4):198-200. PubMed ID: 22208137 [No Abstract] [Full Text] [Related]
33. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Bock NN; Metzger BS; Tapia JR; Blumberg HM Am J Respir Crit Care Med; 1999 Jan; 159(1):295-300. PubMed ID: 9872853 [TBL] [Abstract][Full Text] [Related]
34. Question from the clinician: tuberculosis prophylaxis. Wald E Pediatr Rev; 2003 Oct; 24(10):355. PubMed ID: 14523162 [No Abstract] [Full Text] [Related]
35. Preventive therapy for tuberculous infection: an intervention in need of improvement. Snider DE; Farer LS Am Rev Respir Dis; 1984 Sep; 130(3):355-6. PubMed ID: 6476585 [No Abstract] [Full Text] [Related]
36. Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients. Lui SL; Li FK; Choy BY; Chan TM; Lo WK; Lai KN Transpl Infect Dis; 2004 Mar; 6(1):55-6. PubMed ID: 15225230 [No Abstract] [Full Text] [Related]
37. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients. Casado JL; Moreno S; FortĂșn J; Antela A; Quereda C; Navas E; Moreno A; Dronda F Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825 [TBL] [Abstract][Full Text] [Related]
38. Why are people living with HIV still dying of tuberculosis? Godfrey-Faussett P; Ayles H Lancet; 2016 Mar; 387(10024):1141-3. PubMed ID: 27025319 [No Abstract] [Full Text] [Related]
39. Is INH alone enough for prophylaxis. Sanklecha MU; Raghavan K; Mehta MN Indian Pediatr; 1995 Jan; 32(1):105. PubMed ID: 8617518 [No Abstract] [Full Text] [Related]
40. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Fallab-Stubi CL; Zellweger JP; Sauty A; Uldry C; Iorillo D; Burnier M Int J Tuberc Lung Dis; 1998 Jul; 2(7):525-30. PubMed ID: 9661817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]